Search research articles
Contact Us
Filters
Showing results (201-210 of 273) with videos related to
Page
of 28
Sort By:
Blood
|
March 27, 2007
CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors
Arianne Pérez-García, Rafael De la Cámara, Jose Román-Gómez, et al.
Cancer Medicine
|
May 1, 2021
Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma
Gloria Iacoboni, Guillermo Villacampa, Nuria Martinez-Cibrian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 28, 2011
Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors
Anna Bosch-Vizcaya, Arianne Pérez-García, Salut Brunet, et al.
Leukemia & Lymphoma
|
July 14, 2020
Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis
María Laura Fox, Irene García-Cadenas, Ariadna Martínez Pérez, et al.
Expert Review of Hematology
|
February 17, 2011
Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab
Carlos Vallejo, Eduardo Ríos, Javier de la Serna, et al.
Experimental Hematology
|
June 28, 2003
Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation
Federico Moscardó, Alvaro Urbano-Ispizua, Guillermo F Sanz, et al.
European Journal of Haematology
|
October 7, 2020
Ex vivo T-cell depletion vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft-vs-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation
Juan Montoro, Elisa Roldán, José Luis Piñana, et al.
Bone Marrow Transplantation
|
June 24, 2024
Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies
Maria Laura Fox, Irene García-Cadenas, Victor Navarro, et al.
The Lancet. Haematology
|
January 6, 2024
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack, Monia Marchetti, Mahmoud Aljurf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 7, 2018
CD34<sup>+</sup> Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
Pere Barba, Rodrigo Martino, Qin Zhou, et al.
Page
of 28
Search research articles
Search
Showing results (201-210 of 273) with videos related to
Sort By:
Page
of 28
Blood
|
March 27, 2007
CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors
Arianne Pérez-García, Rafael De la Cámara, Jose Román-Gómez, et al.
Cancer Medicine
|
May 1, 2021
Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma
Gloria Iacoboni, Guillermo Villacampa, Nuria Martinez-Cibrian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 28, 2011
Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors
Anna Bosch-Vizcaya, Arianne Pérez-García, Salut Brunet, et al.
Leukemia & Lymphoma
|
July 14, 2020
Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis
María Laura Fox, Irene García-Cadenas, Ariadna Martínez Pérez, et al.
Expert Review of Hematology
|
February 17, 2011
Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab
Carlos Vallejo, Eduardo Ríos, Javier de la Serna, et al.
Experimental Hematology
|
June 28, 2003
Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation
Federico Moscardó, Alvaro Urbano-Ispizua, Guillermo F Sanz, et al.
European Journal of Haematology
|
October 7, 2020
Ex vivo T-cell depletion vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft-vs-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation
Juan Montoro, Elisa Roldán, José Luis Piñana, et al.
Bone Marrow Transplantation
|
June 24, 2024
Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies
Maria Laura Fox, Irene García-Cadenas, Victor Navarro, et al.
The Lancet. Haematology
|
January 6, 2024
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack, Monia Marchetti, Mahmoud Aljurf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 7, 2018
CD34<sup>+</sup> Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
Pere Barba, Rodrigo Martino, Qin Zhou, et al.
Page
of 28